The shares of eBay Inc. (NASDAQ:EBAY) has been pegged with a rating of Buy by UBS in its latest research note that was published on October 31st, 2018. The research company has also assigned a $42 price target. UBS wasn’t the only research firm that published a report of eBay Inc., with other equities research analysts also giving their opinion on the stock. The Benchmark Company advised investors in its research note published on October 31st, 2018, to Buy the EBAY stock while also putting a $41 price target. The stock had earned Sector Perform rating from RBC Capital Mkts when it published its report on October 31st, 2018. That day the RBC Capital Mkts set price target on the stock to $31. The stock was given Outperform rating by Raymond James in its report released on October 31st, 2018, the day when the price target on the stock was placed at $35. Piper Jaffray was of a view that EBAY is Neutral in its latest report on October 31st, 2018 while giving it a price target of $32. KeyBanc Capital Mkts thinks that EBAY is worth Overweight rating. This was contained in the firm’s report on October 31st, 2018 in which the stock’s price target was also moved to $43.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 20 believe it has the potential for further growth, thus rating it as Hold while 8 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $36.99. The price of the stock the last time has raised by 11.80% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 49.79.
The shares of the company added by 0.72% during the trading session on Thursday, reaching a low of $28.77 while ending the day at $29.47. During the trading session, a total of 15.35 million shares were traded which represents a -16.71% decline from the average session volume which is 13.15M shares. EBAY had ended its last session trading at 29.26. eBay Inc. currently has a market cap of $28.06B, while its P/E ratio stands at 13.10, while its P/E earnings growth sits at 2.68, with a beta of 1.36. eBay Inc. debt-to-equity ratio currently stands at 1.33, while its quick ratio hovers at 1.70. EBAY 52-week low price stands at $26.36 while its 52-week high price is $46.99.
The company in its last quarterly report recorded $0.56 earnings per share which is above the $0.54 predicted by most analysts. The eBay Inc. generated $2,649.00 million in revenue during the last quarter, which is slightly lower than the $2,649.17 million predicted by analysts. In the second quarter last year, the firm recorded $0.53 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 5.36%. eBay Inc. has the potential to record 2.25 EPS for the current fiscal year, according to equities analysts.
Investment analysts at UBS published a research note on November 28th, 2018 where it informed investors and clients that Medtronic plc (NYSE:MDT) is now rated as Buy. The Benchmark Company also rated MDT as Reiterated on October 31st, 2018, with its price target of $41 suggesting that MDT could surge by 7.42% from its current share price. Even though the stock has been trading at $96.49/share, analysts expect it to surge higher by -0.26% to reach $103.95/share. It started the day trading at $96.24 and traded between $93.66 and $96.24 throughout the trading session.
A look at its technical shows that MDT’s 50-day SMA is 94.29 while its 200-day SMA stands at 88.40. The stock has a high of $100.15 for the year while the low is $76.41. The company’s P/E ratio currently sits at 27.80, while the P/B ratio is 2.62. The company’s average trading volume currently stands at 5.16M shares, which means that the short-interest ratio is just 1.65 days. Over the past seven days, the company moved, with its shift of 0.91%. Looking further, the stock has dropped -0.26% over the past 90 days while it gained 11.09% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more MDT shares, increasing its portfolio by +1.14% during the last quarter. This move now sees The Vanguard Group Inc purchasing 1,207,804 shares in the last quarter, thus it now holds 107,438,801 shares of MDT, with a total valuation of $9,650,153,106. Wellington Management Co LLP meanwhile bought more MDT shares in the recently filed quarter, changing its stake to $6,949,990,284 worth of shares. BlackRock Fund Advisors followed the path by increasing its MDT portfolio by +1.50% in the quarter. This means that BlackRock Fund Advisors bought 893,746 shares in the last quarter and now controls 60,359,078 shares of the MDT stock, with the valuation hitting $5,421,452,386.
Similarly, SSgA Funds Management Inc increased its Medtronic plc shares by +4.56% during the recently filed quarter. After buying 2,419,276 shares in the last quarter, the firm now controls 55,502,984 shares of Medtronic plc which are valued at $4,985,278,023. In the same vein, T Rowe Price Associates Inc decreased its Medtronic plc shares by during the most recent reported quarter. The firm sold -830,133 shares during the quarter which decreased its stakes to 23,246,599 shares and is now valued at $2,088,009,522. Following these latest developments, around 0.10% of Medtronic plc stocks are owned by institutional investors and hedge funds.